The Company Reports that Demand for Autism and IDD Care Services is Projected to Grow 10.4% by Year End, Indicating a Significant Opportunity for Providers to Improve their Clinical Operations to Support the Increase in Demand

该公司报告称，到年底，自闭症和碘缺乏病护理服务的需求预计将增长10.4%，这表明提供者有很大的机会改进其临床操作，以支持需求的增长

CentralReach, the leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today announced the acquisition of Behavior Science Technology Inc. (BST), a research-backed treatment fidelity platform designed to collect, measure, and track treatment fidelity for Applied Behavior Analysis (ABA) therapy in a standardized way.

CentralReach是ABA、多学科和特殊教育领域自闭症和IDD护理软件的领先提供商，今天宣布收购Behavior Science Technology Inc.（BST），这是一个以研究为基础的治疗保真度平台，旨在以标准化的方式收集、测量和跟踪应用行为分析（ABA）治疗的治疗保真度。

This strategic acquisition marks a significant milestone in CentralReach’s mission to provide the most complete AI-powered care management platform that arms each member of the care team with the tools they need to improve treatment fidelity, RBT retention, supervision effectiveness, and caregiver engagement while enhancing the quality and consistency of care provided to individuals with autism.

这项战略性收购标志着CentralReach提供最完整的人工智能护理管理平台的使命的一个重要里程碑，该平台为护理团队的每个成员提供了所需的工具，以提高治疗保真度，RBT保留率，监督有效性和护理人员参与度，同时提高为自闭症患者提供护理的质量和一致性。

Once integrated, Care360 alongside CentralReach’s EMR will offer ABA providers a path towards measurement-based care that can be brought to payers to support their approach towards care..

一旦整合，Care360与CentralReach的EMR将为ABA提供商提供一条通往基于测量的护理的道路，可以带给付款人，以支持他们的护理方法。。

Co-Founders, Tricia Glick, BCBA, and Troy Glick, along with Abigail Blackman, PhD, BCBA-D will be joining CentralReach to continue to lead the evolution of BSTperform and its integration into the Care360 platform.

联合创始人Tricia Glick、BCBA和Troy Glick以及BCBA-D博士Abigail Blackman将加入CentralReach，继续领导BSTperform的发展及其与Care360平台的整合。

“I’m thrilled to welcome Tricia, Troy, and Abby to the CentralReach team,” said Chris Sullens, CEO at CentralReach. “Recognizing the importance and potential of a treatment fidelity tool like BST’s, CentralReach made a significant early investment in BST in 2022 to support its growth. Since then, we’ve followed their journey closely while they proved product market fit and validated the material impact treatment fidelity has on clinical quality, outcomes, and retention in the ABA industry.

CentralReach首席执行官克里斯·苏伦斯（ChrisSullens）表示：“我很高兴欢迎特里西亚（Tricia）、特洛伊（Troy）和艾比（Abby）加入CentralReach团队。”。“CentralReach认识到像BST这样的治疗保真度工具的重要性和潜力，于2022年对BST进行了重大的早期投资，以支持其增长。从那时起，我们密切关注他们的历程，同时他们证明了产品市场的适合性，并验证了治疗保真度对ABA行业的临床质量，结果和保留率的重大影响。

We are excited to bring BST’s innovative approach to an even broader audience. With BST’s established success in developing a research-backed platform for treatment fidelity, we believe that joining forces with CentralReach and tightly integrating their IP into our Care360 platform will allow us to leverage AI across our four billion+ clinical data points.

我们很高兴将BST的创新方法带给更广泛的受众。随着BST在开发治疗保真度研究支持平台方面取得的成功，我们相信与CentralReach联手并将其IP紧密整合到我们的Care360平台中，将使我们能够在40多亿个临床数据点上利用人工智能。

This collaboration will enable us to scale these innovations to even more providers, enhancing care and outcomes on a much larger scale.”.

这种合作将使我们能够将这些创新扩展到更多的提供者，从而在更大范围内提高护理和成果。”。

Addressing a Critical Need in Applied Behavior Analysis Care Delivery

解决应用行为分析护理服务的关键需求

The current clinical process for ABA care involves a complex cycle of skill gap assessment, individualized care plan creation, care delivery, data collection and analytics, and plan adjustments, all aimed at improving client outcomes. However, during the care delivery phase, a crucial component—supervision—has traditionally lacked a standardized method for measurement and tracking to ensure that Registered Behavior Technicians (RBTs) consistently adhere to prescribed care plans, ultimately impacting the effectiveness of treatment or treatment fidelity..

目前ABA护理的临床过程涉及技能差距评估，个性化护理计划创建，护理交付，数据收集和分析以及计划调整的复杂循环，所有这些都旨在改善客户的结果。然而，在护理交付阶段，关键组成部分的监督传统上缺乏标准化的测量和跟踪方法，以确保注册行为技术人员（RBT）始终遵守规定的护理计划，最终影响治疗的有效性或治疗保真度。。

BST has developed the industry’s first tech-enabled, research-based platform to address this issue. By providing a standardized approach to collect, measure, and track treatment fidelity, BST offers unprecedented transparency into the care delivery process, empowering clinicians to continuously improve the quality of care..

BST开发了业界第一个基于技术的研究平台来解决这个问题。通过提供标准化的方法来收集，测量和跟踪治疗保真度，BST为护理提供了前所未有的透明度，使临床医生能够不断提高护理质量。。

The Acquisition Provides a Path Towards Stronger RBT Retention and Measurement-Based Care

此次收购为加强RBT保留和基于测量的护理提供了一条途径

The integration of BST’s platform into Care360 brings several key advantages:

BST平台与Care360的集成带来了几个关键优势：

Standardization of Care: The combination of BST’s innovative platform with CentralReach’s existing CR Care360 platform will standardize how care is delivered, providing a clear framework for evaluating and improving care delivery across the board; this will lead to more consistent and effective outcomes for individuals receiving applied behavior analysis care.

护理标准化：BST的创新平台与CentralReach现有的CR Care360平台的结合将标准化护理的提供方式，为全面评估和改进护理提供明确的框架；这将为接受应用行为分析护理的个人带来更一致和有效的结果。

Enhanced RBT Retention: By offering a standardized approach to measuring treatment fidelity, BST’s platform supports RBTs in delivering high-quality care, which research showed led to increased job satisfaction and clinical competency, resulting in a 500% increase in RBT retention; this aligns with CentralReach’s Care360 platform’s focus on supporting the professional development and retention of RBTs, a critical factor in the overall success of care delivery.

增强RBT保留率：通过提供标准化的方法来衡量治疗保真度，BST的平台支持RBT提供高质量的护理，研究表明，这提高了工作满意度和临床能力，导致RBT保留率增加了500%；这与CentralReach的Care360平台专注于支持RBT的专业发展和保留相一致，RBT是护理服务整体成功的关键因素。

Pioneering Measurement-Based Care: The acquisition paves the way for the adoption of measurement-based, or value-based, care within the autism and IDD care industry; the aggregation between BSTperform and CentralReach’s clinical solutions offer providers both a standardized approach and a way to aggregate all critical data providing them with the quantitative evidence needed to demonstrate improved outcomes—a vital component of value-based care models.

开创性的基于测量的护理：此次收购为自闭症和IDD护理行业采用基于测量或基于价值的护理铺平了道路；BSTperform和CentralReach的临床解决方案之间的聚合为提供者提供了一种标准化方法和一种汇总所有关键数据的方法，为他们提供了证明改进结果所需的定量证据，这是基于价值的护理模型的重要组成部分。

“Partnering with CentralReach, the undisputed leader in Autism and IDD care software, was a natural choice for us at BST,” shared Tricia Glick. “CentralReach recognized the potential of our vision and supported us through their investment. We’ve been committed to advancing the field of ABA through our innovative, research-based solutions, and we believe that integrating BSTperform into CentralReach’s comprehensive platform will help further expand our impact.

特里西亚·格里克分享道：“与自闭症和碘缺乏病护理软件无可争议的领导者CentralReach合作，是我们在BST的自然选择。”。“CentralReach认识到我们愿景的潜力，并通过他们的投资支持我们。我们一直致力于通过创新的、基于研究的解决方案推进ABA领域，我们相信将BSTperform整合到CentralReach的综合平台将有助于进一步扩大我们的影响力。

Together, we can accelerate the adoption of standardized treatment fidelity measures and drive meaningful improvements in care delivery and outcomes across the industry.”.

总之，我们可以加速采用标准化的治疗保真度措施，并推动整个行业护理服务和结果的有意义的改进。”。

This latest acquisition is the second that CentralReach made in 2024 and the 14th overall as the company continues to expand its offerings to support the future of Autism and IDD care.

这是CentralReach在2024年进行的第二次收购，也是该公司继续扩大产品范围以支持自闭症和碘缺乏病护理的未来而进行的第14次收购。

To learn more about how BSTperform can improve treatment fidelity, go to behaviorsciencetech.com.

要了解更多有关BSTperform如何提高治疗保真度的信息，请访问behaviorsciencetech.com。

To learn more about how CR Care360 can support more connected care, go to centralreach.com/solutions/care360.

要了解更多有关CR Care360如何支持更多联网护理的信息，请访问centralreach.com/solutions/Care360。

About CentralReach

关于CentralReach

CentralReach is the leading provider of autism and IDD care software, providing the only complete, end-to-end software and services platform that helps children and adults diagnosed with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD) – and those who serve them – unlock potential, achieve better outcomes, and live more independent lives.

CentralReach是自闭症和碘缺乏病护理软件的领先提供商，提供唯一完整的端到端软件和服务平台，帮助被诊断患有自闭症谱系障碍（ASD）和相关智力和发育障碍（IDD）的儿童和成年人以及为其服务的人释放潜力，取得更好的成果，过上更加独立的生活。

With its roots in Applied Behavior Analysis, the company is revolutionizing how the lifelong journey of autism and IDD care is enabled at home, school, and work with powerful and intuitive solutions purpose-built for each care setting..

凭借其应用行为分析的根基，该公司正在彻底改变自闭症和IDD护理的终身旅程在家庭、学校和工作中的实现方式，并为每个护理环境构建了强大而直观的解决方案。。

Trusted by more than 175,000 professionals globally, CentralReach is committed to ongoing product advancement, market-leading industry expertise, world-class client satisfaction, and support of the autism and IDD community to propel autism and IDD care into a new era of excellence. For more information, please visit centralreach.com or follow us on LinkedIn and Facebook..

CentralReach受到全球175000多名专业人士的信任，致力于持续的产品改进、市场领先的行业专业知识、世界级的客户满意度以及对自闭症和IDD社区的支持，以推动自闭症和IDD护理进入一个卓越的新时代。有关更多信息，请访问centralreach.com或在LinkedIn和Facebook上关注我们。。

Originally announced September 17th, 2024

最初于2024年9月17日宣布

TagsAbigail Blackman Behavior Science Technology BST BSTperform CentralReach Chris Sullens CR Care360 Health IT Acquisitions Healthcare M&A Tricia Glick Troy Glick

TagsAbigail Blackman Behavior Science Technology BST BST CentralReach Chris Sullens CR Care360 Health IT收购医疗保健并购Tricia Glick Troy Glick

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息